Parallax Volatility Advisers’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.8M | Buy |
13,470
+13,119
| +3,738% | +$1.84M | ﹤0.01% | 817 |
|
|
2025
Q4 | $43.1K | Sell |
351
-15,051
| -98% | -$1.83M | ﹤0.01% | 1492 |
|
|
2025
Q3 | $1.71M | Sell |
15,402
-72,141
| -82% | -$8.2M | ﹤0.01% | 970 |
|
|
2025
Q2 | $9.71M | Sell |
87,543
-1,092
| -1% | -$116K | 0.02% | 439 |
|
|
2025
Q1 | $9.93M | Sell |
88,635
-80,466
| -48% | -$8.3M | 0.03% | 452 |
|
|
2024
Q4 | $15.6M | Buy |
169,101
+114,146
| +208% | +$10.3M | 0.03% | 419 |
|
|
2024
Q3 | $4.61M | Sell |
54,955
-111,658
| -67% | -$8.52M | 0.01% | 826 |
|
|
2024
Q2 | $11.4M | Buy |
+166,613
| New | +$11.1M | 0.02% | 437 |
|
|
2023
Q3 | – | Sell |
-270
| Closed | -$20.8K | – | 2398 |
|
|
2023
Q2 | $20.8K | Sell |
270
-29,203
| -99% | -$2.33M | ﹤0.01% | 2139 |
|
|
2023
Q1 | $2.45M | Buy |
29,473
+29,293
| +16,274% | +$2.43M | 0.01% | 1166 |
|
|
2022
Q4 | $15.5K | Sell |
180
-12,820
| -99% | -$1.02M | ﹤0.01% | 2512 |
|
|
2022
Q3 | $802K | Sell |
13,000
-5,270
| -29% | -$332K | ﹤0.01% | 1810 |
|
|
2022
Q2 | $1.13M | Buy |
+18,270
| New | +$1.13M | ﹤0.01% | 1591 |
|
|
2022
Q1 | – | Sell |
-42,966
| Closed | -$2.75M | – | 2871 |
|
|
2021
Q4 | $3.12M | Sell |
42,966
-120,132
| -74% | -$8.27M | ﹤0.01% | 934 |
|
|
2021
Q3 | $11.4M | Buy |
+163,098
| New | +$11.5M | 0.01% | 603 |
|
|
2021
Q1 | – | Sell |
-386,844
| Closed | -$22.5M | – | 1415 |
|
|
2020
Q4 | $22.5M | Buy |
386,844
+30,625
| +9% | +$1.85M | 0.02% | 496 |
|
|
2020
Q3 | $22.5M | Buy |
356,219
+305,651
| +604% | +$21.2M | 0.02% | 693 |
|
|
2020
Q2 | $3.89M | Buy |
50,568
+39,078
| +340% | +$2.99M | ﹤0.01% | 1182 |
|
|
2020
Q1 | $859K | Sell |
11,490
-33,696
| -75% | -$2.33M | ﹤0.01% | 1534 |
|
|
2019
Q4 | $2.94M | Sell |
45,186
-22,594
| -33% | -$1.47M | ﹤0.01% | 1120 |
|
|
2019
Q3 | $4.3M | Buy |
67,780
+37,912
| +127% | +$2.48M | ﹤0.01% | 870 |
|
|
2019
Q2 | $2.02M | Buy |
29,868
+11,910
| +66% | +$783K | ﹤0.01% | 1036 |
|
|
2019
Q1 | $1.17M | Sell |
17,958
-51,706
| -74% | -$3.44M | ﹤0.01% | 1209 |
|
|
2018
Q4 | $4.36M | Buy |
69,664
+44,664
| +179% | +$3.12M | 0.01% | 756 |
|
|
2018
Q3 | $1.93M | Buy |
+25,000
| New | +$1.89M | ﹤0.01% | 1036 |
|
|
2018
Q1 | – | Sell |
-95,337
| Closed | -$7.58M | – | 3002 |
|
|
2017
Q4 | $6.83M | Buy |
95,337
+25,600
| +37% | +$1.94M | 0.01% | 512 |
|
|
2017
Q3 | $5.65M | Buy |
+69,737
| New | +$5.33M | 0.01% | 541 |
|
|
2016
Q2 | – | Sell |
-17,757
| Closed | -$1.58M | – | 2877 |
|
|
2016
Q1 | $1.63M | Sell |
17,757
-5,535
| -24% | -$499K | ﹤0.01% | 986 |
|
|
2015
Q4 | $2.36M | Sell |
23,292
-178,587
| -88% | -$18.6M | ﹤0.01% | 958 |
|
|
2015
Q3 | $19.8M | Buy |
201,879
+17,492
| +9% | +$1.94M | 0.04% | 268 |
|
|
2015
Q2 | $21.6M | Sell |
184,387
-182,052
| -50% | -$19.9M | 0.05% | 275 |
|
|
2015
Q1 | $36M | Sell |
366,439
-24,105
| -6% | -$2.45M | 0.09% | 184 |
|
|
2014
Q4 | $36.8M | Buy |
390,544
+270,124
| +224% | +$27.9M | 0.11% | 185 |
|
|
2014
Q3 | $12.8M | Buy |
120,420
+120,383
| +325,359% | +$11.8M | 0.04% | 370 |
|
|
2014
Q2 | $3K | Sell |
37
-49,613
| -100% | -$3.86M | ﹤0.01% | 3936 |
|
|
2014
Q1 | $3.52M | Sell |
49,650
-25,239
| -34% | -$1.98M | 0.02% | 451 |
|
|
2013
Q4 | $5.62M | Buy |
74,889
+73,498
| +5,284% | +$5.12M | 0.03% | 407 |
|
|
2013
Q3 | $87K | Buy |
+1,391
| New | +$83.1K | ﹤0.01% | 1507 |
|
Other funds holding GILD
VCM
VPM
Parallax Volatility Advisers's GILD Position: Q1 2026 in Review
Parallax Volatility Advisers increased its Gilead Sciences (GILD) stake by 3,738% in Q1 2026, buying an estimated $1.84M and bringing the position to 13,470 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #817.
Parallax Volatility Advisers first reported a position in GILD in Q3 2013 and has held it in 38 quarters since. The position peaked at $36.8M in Q4 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Parallax Volatility Advisers held 13,470 shares of Gilead Sciences worth $1.8M as of Q1 2026.
- Parallax Volatility Advisers bought 13,119 Gilead Sciences shares in Q1 2026, an estimated $1.84M.
- Gilead Sciences made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #817 holding.
- Parallax Volatility Advisers first reported a position in Gilead Sciences in Q3 2013 and has held it in 38 quarters since.
- Parallax Volatility Advisers's Gilead Sciences position peaked at $36.8M in Q4 2014.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.